Công ty Dược phẩm Haxi: Tình hình sản xuất kinh doanh bình thường Không có thông tin quan trọng cần phải công bố mà chưa được công bố

The information on January 13th, Jinshi Data, Harbin Pharmaceutical Group, issued an announcement of abnormal changes. After the company’s self-inspection, the current production and operation status of the company is normal, and there have been no major changes in the internal and external operating environment. There are no significant matters affecting the abnormal fluctuations in the company’s stock trading prices, and there are no significant information that should have been disclosed but not disclosed.